WW International's Weight Watchers Med+ Will Support Medicare Members Seeking Access To GLP-1s Under The Medicare GLP-1 Bridge Program

Through the Medicare GLP-1 Bridge Program, eligible beneficiaries purchase GLP-1 medications for weight loss, including Zepbound®, KwikPen®, Foundayo®, and Wegovy® pen and pill, for $50 per month.

The program will run from July 1, 2026 through December 31, 2027.

In addition to prescribing medication when appropriate and managing care for these medications, Weight Watchers helps Med+ members navigate insurance coverage, paperwork, and prior authorizations so they can easily access care.

To qualify for the Medicare Bridge program, you must have Medicare Part D, meet clinical eligibility, and have a prescription for an eligible GLP-1 medication.

This medication must be used alongside ongoing lifestyle changes, including nutrition and physical activity, to support weight loss and maintenance.

As Medicare beneficiaries consider GLP-1 treatment, Weight Watchers, a trusted brand for older adults on their health journey, offers comprehensive care beyond providing a prescription.

Our Med + program blends clinical oversight with behavioral tools to deliver sustainable results.

In addition to clinical care, members access nutrition support, medication tracking, refill reminders, and expert GLP-1 coaches through our integrated GLP-1 Success Program.

Crucially for older adults, the program includes tailored strength-building guidance to preserve muscle mass and reduce the risk of frailty and falls.

Weight Watchers data show that Med+ members prescribed a GLP-1 medication who regularly engaged with the GLP-1 Success Program lost 29.1% more body weight on average at 12 months than those who did not engage in behavioral support.1 In addition, 73% of Med+ members given the GLP-1 Success Program say that Weight Watchers Med+ helps minimize weight-loss medication side effects.2